Venous Thromboembolism and Cardioembolism » Cancer Associated Thrombosis

Abstract Number: PB2136

A Newly Developed Kit for High-Sensitivity Measurement of TF-Dependent Procoagulant Activity on Microvesicles Purified by High-Speed Centrifugation

T. Bouriche¹, C. Judicone¹, C. Franco¹, L. Vallier², V. Cucini³, O. Mathieu², F. Dignat-George⁴, R. Lacroix⁴, P. Poncelet¹

Abstract Number: PB2097

Amelioration of the Pathologic Changes in the Hepatocyte-Specific BRAFV600E Mutated Mice by Administration of Aspirin

H. Tanaka¹, K. Horioka², K. Yamazaki³, K. Ogawa⁴

Abstract Number: PB2154

Anticoagulation Therapy as Prevention of Cancer Relapce

A. Vorobev, A. Makatsariya, V. Bitsadze, J. Khizroeva, A. Solopova, V. Sannikova, S. Petrova

Abstract Number: PB2159

Anticoagulation Therapy Management in Oncological Patients: Experience in a Center

A. Pimentel Feliciano, A. Ortiz López, M. Dobón Rebollo, L. Palomera Bernal, O. Gavín Sebastián

Abstract Number: PB2168

Antimetastatic Profile of Bovine Intestinal Heparin and its Low Anticoagulant Activity Derivative

M. Sá Pereira^1,2, K.V. Micheli¹, C.R. Fernades¹, A.C.E.S. Vilela-Silva^2,3, A.G.F. Lima⁴, A.L. Guedes¹, F.F. Ferreira⁵, A.M.F. Tovar^1,2, M.S.G. Pavão^1,2, P.A.S. Mourão^1,2

Abstract Number: PB2140

Apixaban Levels In Cancer-Associated Thrombosis In Low-Weight Individuals

V. Bravo-Villa¹, J. Romero², E. Rojas-Saldivar², R. Villa², M. Cervantes-Alarcón², P. Baz², G. Cesarman Maus²

Abstract Number: PB2112

Are Patients with an Active Cancer and those with a History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding while on Anticoagulants?

C. Frere^1,2, M. Lejeune¹, N. Janus³

Abstract Number: PB2145

Aspects of Cancer-Related Venous Thrombosis in a cohort of 207 Tunisian Patients

M. Mama¹, F. Said¹, I. Naceur¹, H. Baccouche², I. Ben Ghorbel¹, M. Lamloum¹, M.H. Houman¹, N. Ben Romdhane²

Abstract Number: PB2121

Assessment of the Ottawa Score in the Prediction of Recurrent Venous Thromboembolism in Patients Treated for Lymphoma

J. Rupa-Matysek¹, A. Hoppe¹, M.M. Joks², M. Joks¹, L. Gil¹

Abstract Number: PB2131

Biomarkers of Venous Thromboembolism Recurrence After Discontinuation of Anticoagulation for Cancer-Associated Thrombosis (HISPALIS- Study)

J. Oto¹, V. Sánchez-López², E. Arellano-Orden², A. Solier-López³, S. Marín-Romero³, L. Jara-Palomares³, T. Elias-Hernández³, M.I. Asencio-Cruz³, I. Blasco-Esquivias⁴, M. Rodriguez-de-la-Borbolla⁵, J.M. Sánchez-Díaz³, F.J. Rodriguez-Martorell⁶, P. Medina-Badenes¹, R. Otero-Candelera³

Abstract Number: PB2124

Bleeding Risk Assessment Model for Older Multiple Myeloma Patients on Immunomodulatory Drugs (IMIDs)

A. Li¹, G. Warnick², E. Libby³, D. Garcia³, G. Lyman²

Abstract Number: PB2179

Cancer Associated Thrombosis: Are DOACs a Treatment Option? Systematic Review and Meta-analysis of Randomised Controlled Trials

R. Alikhan, M. Rees

Abstract Number: PB2173

Cancer Patients Has Lower Plasmin Generation by Simultaneous Thrombin and Plasmin Assay Evaluation

G. da Silva Souza Gois, M. Evelyn Alves de Almeida, T. Ramires Rodrigues Alencar, S. Aparecida de Lima Montalvão, B. Moraes Martinelli, I. Macedo Toni, J. Barreto Carvalheira, N. Adami Andreollo, M. Etchebehere, J. Cesar Teixeira, J. Maria Annichino-Bizzacchi, ADVENTH Cancer Investigators

Abstract Number: PB2177

Cancer Site and Distant Metastasis at Diagnosis Predict the Risk of VTE in Cancer

S.K. Braekkan¹, M.E. Gabrielsen², B. Brumpton², K. Hveem², J.-B. Hansen¹

Abstract Number: PB2143

Catheter-Associated Upper Extremities Deep Vein Thrombosis in Cancer Patients: Does Anticoagulation Time Matter?

A. Dalla Salda, E. Spaggiari, B. Abbate, M. Iotti, L. Depietri, S. Corradini, I. Lambertini, M.R. Veropalumbo, A. Ghirarduzzi

Abstract Number: PB2163

Cerebral Sinus Venous Thrombosis in Children with Leukemia: Single-institution Report

I. Melnichenko^1,2, L. Krmoyan^1,2, H. Khachatryan³, A. Zakharyan^2,4, N. Martirosyan², S. Hovhannisyan², M. Gizhlaryan^1,2, S. Danielyan⁵, G. Tamamyan^1,2, L. Vagharshakyan^1,2

Abstract Number: PB2102

Clinical Outcome of Anticoagulation for Acute Venous Thromboembolism Associated with Different Types of Cancer

W. Wysokinski¹, D.T. Vlazny¹, R.D. McBane¹, D.O. Hodge², D.A. Froehling¹, D.E. Houghton¹, L.G. Peterson¹, A.I. Casanegra¹

Abstract Number: PB2146

Clinical Outcome of Splanchnic and Usual Site Venous Thrombosis in Patients with Solid Cancer

E. Valeriani¹, M. Di Nisio², N. Riva³, L.M. Caiano⁴, E. Porreca¹, S.M. Bang⁵, J. Beyer-Westendorf⁶, M.T. Sartori⁷, G. Barillari⁸, R.C. Santoro⁹, R. Duce¹⁰, P. Kamphuisen¹¹, A. Alatri¹², A. Malato¹³, G. Vidili¹⁴, D. Oh¹⁵, S. Schulman¹⁶, W. Ageno⁴, International Registry on Splanchnic Vein Thrombosis (IRSVT) Study Group

Abstract Number: PB2176

Clinical Presentation and Outcomes of Cancer-associated Distal Deep Vein Thrombosis: Data from the RIETE Registry

J.-P. Galanaud¹, J. Trujillo-Santos², B. Bikdeli³, V. Rosa⁴, A. Visona⁵, J.A. Nieto⁶, L. Mazzolai⁷, S. Soler⁸, M. Monreal⁹, RIETE Investigators

Abstract Number: PB2165

Cooperation about the Treatment of the Venous Thromboembolism in Cancer Institute Hospitals and Neighboring Cooperation Acute Hospitals

C. Yasuda¹, T. Shiga², K. Iwasa³, M. Shoji³, T. Takahashi⁴, Y. Nishihata⁵, K. Suzuki⁴